Baxter International Inc
BAX
23.97
-0.39
-1.60%
Baxter International Inc
US · BAX
#1293 by market cap
Listed 2015
23.97
-0.39
-1.60%
Live - 5344 symbols - heartbeat 125s ago
· 2026-10-08 04:03
Pre-market
23.95
-0.08%
After-hours
23.97
0.00%
Overnight
23.95
-0.08%
- Market cap
- 12.39B
- P/E (TTM)i
- -11.52
- P/Bi
- 2.00
- EPSi
- -1.87
- Div yieldi
- 0.83%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on BAX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 111.11% +0.06pp
- Institutions
- 827 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund100.09%
Hedge Fund3.22%
Public Company3.12%
Private Company2.41%
Government Pension Fund1.07%
Sovereign Wealth Fund0.80%
Individual/Insider0.42%
Family Office/Trust0.17%
Insurance Company0.11%
Top holders as of 2026-06-30
BlackRock
15.83% · 81.84M sh
Pzena Investment Management, Inc.
12.63% · 65.30M sh
Dodge & Cox
11.29% · 58.39M sh
Vanguard Capital Management, LLC
7.09% · 36.65M sh
FMR
6.75% · 34.90M sh
Vanguard Portfolio Management, LLC
4.65% · 24.06M sh
State Street Global Advisors
3.98% · 20.60M sh
Strategic Advisers LLC
3.68% · 19.01M sh
Greenhaven Associates Inc
2.76% · 14.29M sh
Geode Capital Management, LLC
2.73% · 14.12M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Jose Almeida | Chairperson & CEO | 0.11% |
| Jeanne Mason | ?Executive VP & Chief Human Resources Officer | 0.04% |
| Heather Knight | Executive VP & Group President of Medical Products and Therapies | 0.03% |
| Reazur Rasul | Executive VP & Group President of Healthcare Systems and Technologies | 0.02% |
| Christopher Toth | Executive VP & Group President of Kidney Care | 0.02% |
| David Rosenbloom | Executive Vice President | 0.02% |
| Maria Soriano | -- | 0.01% |
| Joel Grade | Chief Financial Officer | 0.01% |
| David Shafer | Lead Independent Director | 0.01% |
| Andrew Hider | Chief Executive Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | John Rogers | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-09-14 | Bernie Heine | Interim Chief Accounting Officer & Controller | Initial Statement of Beneficial | 0 | -- |
| 2026-09-01 | Andrew Hider | Chief Executive Officer | Sale to Issuer | -54,276 | $25.70 |
| 2026-09-01 | Julie Foster | President of Front Line Care | Sale to Issuer | -2,098 | $25.70 |
| 2026-08-31 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -750 | $25.48 |
| 2026-06-01 | Steven Wallace | President of Advanced Surgery | Sale to Issuer | -153 | $18.68 |
| 2026-06-01 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -321 | $18.68 |
| 2026-05-31 | Anita Zielinski | Chief Accounting Officer | Other Acquisition | +13,426 | -- |
| 2026-05-04 | Michael McDonnell | Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | Amy McBride-Wendell | Independent Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | Patricia Morrison | Independent Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | Nancy Schlichting | Independent Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | David Shafer | Lead Independent Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | Jeffrey Craig | Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | David Wilkes | Independent Director | Other Acquisition | +12,836 | -- |
| 2026-05-04 | William Ampofo | Director | Other Acquisition | +12,836 | -- |
| 2026-03-31 | Steven Wallace | President of Advanced Surgery | Initial Statement of Beneficial | 0 | -- |
| 2026-03-31 | Julie Foster | President of Front Line Care | Initial Statement of Beneficial | 0 | -- |
| 2026-03-31 | James Teaff | President of Care & Connectivity Solutions | Initial Statement of Beneficial | 0 | -- |
| 2026-03-05 | Joel Grade | Chief Financial Officer | Sale to Issuer | -8,153 | $17.69 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:03:16 · For reference only, not investment advice and not tailored to your situation.